跳至主要内容
临床试验/NL-OMON40547
NL-OMON40547已完成不适用

Psychiatric co-morbidity in dystonia-(plus) syndromes: is serotonin the common pathway? - Dystonia en Psychiatry

niversitair Medisch Centrum Groningen0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 99(—)

入选标准

  • Patients with clinically confirmed diagnosis of idiopathic cervical dystonia (CD) or
  • Carrier of mutation in DYT11 gene for myoclonus-dystonia (MD) or
  • Carrier of mutation in GTP-cyclohydrolase 1 gene for dopa-responsive dystonia (DRD)
  • Only adults ( >= 18 years old) will be eligible for PET-scans

排除标准

  • General exclusion criteria: other neurological conditions past of present, treatment with deep brain stimulation ;Additional exclusion criteria from the PET-scanning:
  • - SSRI use in the past 6 months to or during the study
  • - use of medication with a known effect on serotonin receptors or transporters
  • - pregnancy or nursing
  • - exhibition to a radiation dose for other reasons, exceeding the maximum annual dose

研究者

相似试验

Psychiatric co-morbidity in dystonia-(plus)... | 临床试验